EP 1482946 A1 20041208 - PROGESTERONE ORAL DRUG DELIVERY SYSTEM
Title (en)
PROGESTERONE ORAL DRUG DELIVERY SYSTEM
Title (de)
PROGESTERONHALTIGES ORAL ANZUWENDENDES WIRKSTOFFABGABESYSTEM
Title (fr)
SYSTEME D'ADMINISTRATION DE MEDICAMENT ORAL A BASE DE PROGESTERONE
Publication
Application
Priority
US 0207562 W 20020314
Abstract (en)
[origin: WO03077923A1] Provided is an oral dosage form suitable to deliver a combined dosage of progesterone and which upon delivery through the gastrointestinal tract provides a blood concentration of from about 0.1 ng/ml to about 400 ng/ml progesterone; said dosage form comprising a combination that includes (a) a first solid form comprising from about 25 mg to about 500 mg micronized progesterone in a solid polyethylene glycol carrier having an average molecular weight of from about 1000 to 10,000 and constituting at least about 30 % of said first solid form; and (b) a second solid form comprising an estrogen.
IPC 1-7
IPC 8 full level
A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 31/565 (2006.01); A61K 31/57 (2006.01); A61K 47/34 (2006.01)
CPC (source: EP)
A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 9/2072 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01)
Citation (search report)
See references of WO 03077923A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 03077923 A1 20030925; AU 2002242339 A1 20030929; CA 2479295 A1 20030925; CN 1622810 A 20050601; EP 1482946 A1 20041208; JP 2005526083 A 20050902
DOCDB simple family (application)
US 0207562 W 20020314; AU 2002242339 A 20020314; CA 2479295 A 20020314; CN 02828612 A 20020314; EP 02707980 A 20020314; JP 2003575976 A 20020314